Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
Affiliation
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, BostonIssue Date
2018
Metadata
Show full item recordCitation
Efstathiou JA, Choudhury A, Kiltie AE. Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer. JAMA Surg. 2018 Nov 21.Journal
JAMA SurgeryDOI
10.1001/jamasurg.2018.4370PubMed ID
30477011Additional Links
https://dx.doi.org/10.1001/jamasurg.2018.4370Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1001/jamasurg.2018.4370
Scopus Count
Collections
Related articles
- Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer.
- Authors: Molitoris JK, Simone CB 2nd
- Issue date: 2019 Feb 1
- Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer-Reply.
- Authors: Williams SB, Kamat AM, Mehta HB
- Issue date: 2019 Feb 1
- Bladder-sparing treatment of invasive bladder cancer.
- Authors: Rivera I, Wajsman Z
- Issue date: 2000 Jul-Aug
- [Organ-sparing treatment of bladder cancer].
- Authors: Niedworok C, Shaleva A, Rübben H, Stenzl A
- Issue date: 2016 May
- Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
- Authors: Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson TA, Kamat AM
- Issue date: 2018 Oct 1